]> 2026-04-29T22:02:18+00:00 Oncology 14 en Oncology AL-4 0 en AL-4 Abemaciclib 0 en Abemaciclib Acute myeloid leukemia 0 en Acute myeloid leukemia Acute promyelocytic leukemia 0 en Acute promyelocytic leukemia Angioimmunoblastic T-cell lymphoma 0 en Angioimmunoblastic T-cell lymphoma Azacitidine 0 en Azacitidine Bispecific T-cell engager 0 en Bispecific T-cell engager Bony metastases 0 en Bony metastases Bortezomib 0 en Bortezomib Brentuximab vedotin 0 en Brentuximab vedotin Cancer of unknown primary 0 en Cancer of unknown primary Carcinoid syndrome 0 en Carcinoid syndrome Cavitary lung disease 0 en Cavitary lung disease Chimeric antigen receptor T-cell therapy 0 en Chimeric antigen receptor T-cell therapy Chronic lymphocytic leukemia 0 en Chronic lymphocytic leukemia Chronic myeloid leukemia 0 en Chronic myeloid leukemia Chronic myelomonocytic leukemia 0 en Chronic myelomonocytic leukemia Colorectal cancer 0 en Colorectal cancer Cytokine release syndrome 0 en Cytokine release syndrome DPACE 0 en DPACE Daratumumab 0 en Daratumumab Durvalumab 0 en Durvalumab ECOG 0 en ECOG Enfortumab vedotin 0 en Enfortumab vedotin Everolimus 0 en Everolimus Fever in a patient with cancer 0 en Fever in a patient with cancer Follicular lymphoma 0 en Follicular lymphoma Hand-Schüller-Christian disease 0 en Hand-Schüller-Christian disease Head and neck cancers 0 en Head and neck cancers Hepatocellular carcinoma 0 en Hepatocellular carcinoma Human T-lymphotropic virus 0 en Human T-lymphotropic virus Hypercalcemia of malignancy 0 en Hypercalcemia of malignancy Ibrutinib 0 en Ibrutinib Immune effector cell-associated neurotoxicity syndrome 0 en Immune effector cell-associated neurotoxicity syndrome Incidental adrenal masses 0 en Incidental adrenal masses Incidentalomas 0 en Incidentalomas Infections associated with malignancy 0 en Infections associated with malignancy Kaposi sarcoma 0 en Kaposi sarcoma Lambert-Eaton myasthenic syndrome 0 en Lambert-Eaton myasthenic syndrome Langerhans cell histiocytosis 0 en Langerhans cell histiocytosis Lenalidomide 0 en Lenalidomide Lenvatinib 0 en Lenvatinib Leukemia 0 en Leukemia Li-Fraumeni syndrome 0 en Li-Fraumeni syndrome Lung and brain masses 0 en Lung and brain masses Lung cancer 0 en Lung cancer Lymphoma 0 en Lymphoma Lymphoplasmacytic lymphoma 0 en Lymphoplasmacytic lymphoma MATRix 0 en MATRix Marginal zone lymphoma 0 en Marginal zone lymphoma Meningioma 0 en Meningioma Mogamulizumab 0 en Mogamulizumab Multiple endocrine neoplasia 0 en Multiple endocrine neoplasia Multiple endocrine neoplasia type 1 0 en Multiple endocrine neoplasia type 1 Multiple myeloma 0 en Multiple myeloma Myelodysplastic disorders 0 en Myelodysplastic disorders Myeloproliferative disorders 0 en Myeloproliferative disorders Myeloproliferative neoplasm 0 en Myeloproliferative neoplasm Osimertinib 0 en Osimertinib Plasma cell granuloma 0 en Plasma cell granuloma Primary CNS lymphoma 0 en Primary CNS lymphoma Radiation pneumonitis 0 en Radiation pneumonitis Radiation recall pneumonitis 0 en Radiation recall pneumonitis Radiation-induced lung injury 0 en Radiation-induced lung injury Renal cell carcinoma 0 en Renal cell carcinoma Small cell lung cancer 0 en Small cell lung cancer Sokal score 0 en Sokal score Sorafenib 0 en Sorafenib Stiff person syndrome 0 en Stiff person syndrome Sézary syndrome 0 en Sézary syndrome Thalidomide 0 en Thalidomide Toronto HCC risk index 0 en Toronto HCC risk index Tumour lysis syndrome 0 en Tumour lysis syndrome VIP regimen 0 en VIP regimen Zanubrutinib 0 en Zanubrutinib Paraneoplastic syndromes 14 en Paraneoplastic syndromes AL-4 0 en AL-4 Abemaciclib 0 en Abemaciclib Acute myeloid leukemia 0 en Acute myeloid leukemia Acute promyelocytic leukemia 0 en Acute promyelocytic leukemia Angioimmunoblastic T-cell lymphoma 0 en Angioimmunoblastic T-cell lymphoma Azacitidine 0 en Azacitidine Bispecific T-cell engager 0 en Bispecific T-cell engager Bony metastases 0 en Bony metastases Bortezomib 0 en Bortezomib Brentuximab vedotin 0 en Brentuximab vedotin Cancer of unknown primary 0 en Cancer of unknown primary Carcinoid syndrome 0 en Carcinoid syndrome Cavitary lung disease 0 en Cavitary lung disease Chimeric antigen receptor T-cell therapy 0 en Chimeric antigen receptor T-cell therapy Chronic lymphocytic leukemia 0 en Chronic lymphocytic leukemia Chronic myeloid leukemia 0 en Chronic myeloid leukemia Chronic myelomonocytic leukemia 0 en Chronic myelomonocytic leukemia Colorectal cancer 0 en Colorectal cancer Cytokine release syndrome 0 en Cytokine release syndrome DPACE 0 en DPACE Daratumumab 0 en Daratumumab Durvalumab 0 en Durvalumab ECOG 0 en ECOG Enfortumab vedotin 0 en Enfortumab vedotin Everolimus 0 en Everolimus Fever in a patient with cancer 0 en Fever in a patient with cancer Follicular lymphoma 0 en Follicular lymphoma Hand-Schüller-Christian disease 0 en Hand-Schüller-Christian disease Head and neck cancers 0 en Head and neck cancers Hepatocellular carcinoma 0 en Hepatocellular carcinoma Human T-lymphotropic virus 0 en Human T-lymphotropic virus Hypercalcemia of malignancy 0 en Hypercalcemia of malignancy Ibrutinib 0 en Ibrutinib Immune effector cell-associated neurotoxicity syndrome 0 en Immune effector cell-associated neurotoxicity syndrome Incidental adrenal masses 0 en Incidental adrenal masses Incidentalomas 0 en Incidentalomas Infections associated with malignancy 0 en Infections associated with malignancy Kaposi sarcoma 0 en Kaposi sarcoma Lambert-Eaton myasthenic syndrome 0 en Lambert-Eaton myasthenic syndrome Langerhans cell histiocytosis 0 en Langerhans cell histiocytosis Lenalidomide 0 en Lenalidomide Lenvatinib 0 en Lenvatinib Leukemia 0 en Leukemia Li-Fraumeni syndrome 0 en Li-Fraumeni syndrome Lung and brain masses 0 en Lung and brain masses Lung cancer 0 en Lung cancer Lymphoma 0 en Lymphoma Lymphoplasmacytic lymphoma 0 en Lymphoplasmacytic lymphoma MATRix 0 en MATRix Marginal zone lymphoma 0 en Marginal zone lymphoma Meningioma 0 en Meningioma Mogamulizumab 0 en Mogamulizumab Multiple endocrine neoplasia 0 en Multiple endocrine neoplasia Multiple endocrine neoplasia type 1 0 en Multiple endocrine neoplasia type 1 Multiple myeloma 0 en Multiple myeloma Myelodysplastic disorders 0 en Myelodysplastic disorders Myeloproliferative disorders 0 en Myeloproliferative disorders Myeloproliferative neoplasm 0 en Myeloproliferative neoplasm Osimertinib 0 en Osimertinib Plasma cell granuloma 0 en Plasma cell granuloma Primary CNS lymphoma 0 en Primary CNS lymphoma Radiation pneumonitis 0 en Radiation pneumonitis Radiation recall pneumonitis 0 en Radiation recall pneumonitis Radiation-induced lung injury 0 en Radiation-induced lung injury Renal cell carcinoma 0 en Renal cell carcinoma Small cell lung cancer 0 en Small cell lung cancer Sokal score 0 en Sokal score Sorafenib 0 en Sorafenib Stiff person syndrome 0 en Stiff person syndrome Sézary syndrome 0 en Sézary syndrome Thalidomide 0 en Thalidomide Toronto HCC risk index 0 en Toronto HCC risk index Tumour lysis syndrome 0 en Tumour lysis syndrome VIP regimen 0 en VIP regimen Zanubrutinib 0 en Zanubrutinib INST 102 en INST Subcategory of 102 en Subcategory of